Haploinsufficiency in the Mitochondrial Protein CHCHD4 Reduces Brain Injury in a Mouse Model of Neonatal Hypoxia-Ischemia

Yanyan Sun,Tao Li,Cuicui Xie,Yiran Xu,Kai Zhou,Juan Rodriguez,Wei Han,Xiaoyang Wang,Guido Kroemer,Nazanine Modjtahedi,Klas Blomgren,Changlian Zhu
DOI: https://doi.org/10.1038/cddis.2017.196
2017-01-01
Cell Death and Disease
Abstract:Mitochondria contribute to neonatal hypoxic-ischemic brain injury by releasing potentially toxic proteins into the cytosol. CHCHD4 is a mitochondrial intermembrane space protein that plays a major role in the import of intermembrane proteins and physically interacts with apoptosis-inducing factor (AIF). The purpose of this study was to investigate the impact of CHCHD4 haploinsufficiency on mitochondrial function and brain injury after cerebral hypoxia-ischemia (HI) in neonatal mice. CHCHD4 +/− and wild-type littermate mouse pups were subjected to unilateral cerebral HI on postnatal day 9. CHCHD4 haploinsufficiency reduced insult-related AIF and superoxide dismutase 2 release from the mitochondria and reduced neuronal cell death. The total brain injury volume was reduced by 21.5% at 3 days and by 31.3% at 4 weeks after HI in CHCHD4 +/− mice. However, CHCHD4 haploinsufficiency had no influence on mitochondrial biogenesis, fusion, or fission; neural stem cell proliferation; or neural progenitor cell differentiation. There were no significant changes in the expression or distribution of p53 protein or p53 pathway-related genes under physiological conditions or after HI. These results suggest that CHCHD4 haploinsufficiency afforded persistent neuroprotection related to reduced release of mitochondrial intermembrane space proteins. The CHCHD4-dependent import pathway might thus be a potential therapeutic target for preventing or treating neonatal brain injury.
What problem does this paper attempt to address?